Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.02 USD | +0.08% | -1.48% | -13.41% |
May. 23 | Cantor Fitzgerald Adjusts Alkermes Price Target to $48 From $43, Maintains Overweight Rating | MT |
May. 02 | UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.41% | 4.06B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+42.95% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Transcript : Alkermes plc Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 11